The effect of bariatric procedures on selected laboratory parameters of patients from rural areas in Poland.

Background: Rural areas in Poland are inhabited by over 15 million people, i.e. 39.5% of Polish population, including about 5 million rural residents in the Podlaskie province. The incidence of obesity is associated with increased prevalence of obesity-related conditions. Studies that have been conducted do not confirm the efficacy of conservative treatment of obesity, but show that bariatric procedures produce the best longterm results.

Objectives: The aim of the study was to present the effects of bariatric obesity treatments (laparoscopic adjustable gastric banding [LAGB], sleeve gastrectomy [SG], Roux-en-Y gastric bypass [RYGB]) on body mass index (BMI), selected diabetes control parameters, dyslipidemia, hepatic and renal enzymes, blood count and hypertension control.

Material And Methods: The study group comprised a total of 100 consecutive patients from rural areas qualified for bariatric procedures. Most of the patients (69.07%) underwent SG; 11.34% underwent LAGB; and 19.59% underwent RYGB. Comorbidities included hypertension (35%), type 2 diabetes (52%) and hyperlipidemia (15%). Glucose, insulin, HbA1C, alanine and aspartate aminotransferase, bilirubin, total and fraction cholesterol, creatinine, urea, uric acid and CRP levels, as well as blood count and blood pressure values, were assessed prior to surgery and during follow-up visits 3 and 6 months after the procedures. BMI, percentage of excess weight loss (%EWL) and percentage of excess body mass index loss (%EBMIL) were assessed.

Results: Consistent, significant decreases in BMI were observed 3 months (39.31 ± 4.70) and 6 months (35.74 ± 4.52) after surgery. The largest BMI reduction at the 6-month follow up was observed for SG (12.29%), and the smallest was observed for LAGB (9.02%).

Conclusions: Improvements in the general health status of the patients were observed, as well as normalization of metabolic parameters (glucose, cholesterol, triglycerides, hepatic enzymes).